Structure |
Chemical Name |
CAS |
MF |
![Entinostat](/CAS/GIF/209783-80-2.gif) |
Entinostat |
209783-80-2 |
C21H20N4O3 |
![Vorinostat](/CAS/GIF/149647-78-9.gif) |
Vorinostat |
149647-78-9 |
C14H20N2O3 |
![Sodium 4-phenylbutyrate](/CAS/GIF/1716-12-7.gif) |
Sodium 4-phenylbutyrate |
1716-12-7 |
C10H13NaO2 |
![Tacedinaline](/CAS/GIF/112522-64-2.gif) |
Tacedinaline |
112522-64-2 |
C15H15N3O2 |
![Panobinostat](/CAS/GIF/404950-80-7.gif) |
Panobinostat |
404950-80-7 |
C21H23N3O2 |
![N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide](/CAS/GIF/726169-73-9.gif) |
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide |
726169-73-9 |
C23H20N6O |
![Belinostat (PXD101)](/CAS/GIF/414864-00-9.gif) |
Belinostat (PXD101) |
414864-00-9 |
C15H14N2O4S |
![Pracinostat](/CAS/GIF/929016-96-6.gif) |
Pracinostat |
929016-96-6 |
C20H30N4O2 |
![(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone](/CAS/GIF/128517-07-7.gif) |
(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone |
128517-07-7 |
C24H36N4O6S2 |
![MC1568](/CAS/GIF/852475-26-4.gif) |
MC1568 |
852475-26-4 |
C17H15FN2O3 |
![M344](/CAS/GIF/251456-60-7.gif) |
M344 |
251456-60-7 |
C16H25N3O3 |
![CUDC-101](/CAS/GIF/1012054-59-9.gif) |
CUDC-101 |
1012054-59-9 |
C24H26N4O4 |
![CRA-02478](/CAS/GIF/783355-60-2.gif) |
CRA-02478 |
783355-60-2 |
C21H23N3O5 |
![ACY-1215](/CAS/GIF/1316214-52-4.gif) |
ACY-1215 |
1316214-52-4 |
C24H27N5O3 |
![tasquinimod](/CAS/20150408/GIF/254964-60-8.gif) |
tasquinimod |
254964-60-8 |
C20H17F3N2O4 |
![JNJ-26481585](/CAS/GIF/875320-29-9.gif) |
JNJ-26481585 |
875320-29-9 |
C21H26N6O2 |
![PCI 34051](/CAS/GIF/950762-95-5.gif) |
PCI 34051 |
950762-95-5 |
C17H16N2O3 |
![PI3K/HDAC Inhibitor](/CAS/GIF/1339928-25-4.gif) |
PI3K/HDAC Inhibitor |
1339928-25-4 |
C23H24N8O4S |
![RGFP 109](/CAS/20150408/GIF/1215493-56-3.gif) |
RGFP 109 |
1215493-56-3 |
C20H25N3O2 |
![ITF2357](/CAS/20150408/GIF/732302-99-7.gif) |
ITF2357 |
732302-99-7 |
C24H30ClN3O5 |
![2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-](/CAS/GIF/404951-53-7.gif) |
2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- |
404951-53-7 |
C22H25N3O3 |
![Droxinostat](/CAS/GIF/99873-43-5.gif) |
Droxinostat |
99873-43-5 |
C11H14ClNO3 |
![LMK-235](/CAS/20150408/GIF/1418033-25-6.gif) |
LMK-235 |
1418033-25-6 |
C15H22N2O4 |
![4SC-202 (free base)](/CAS/20180808/GIF/910462-43-0.gif) |
4SC-202 (free base) |
910462-43-0 |
C23H21N5O3S |
![RGFP966](/CAS/20180808/GIF/1396841-57-8.gif) |
RGFP966 |
1396841-57-8 |
C21H19FN4O |
![Tubacin](/CAS/GIF/537049-40-4.gif) |
Tubacin |
537049-40-4 |
C41H43N3O7S |
![4SC-201](/CAS/20150408/GIF/864814-88-0.gif) |
4SC-201 |
864814-88-0 |
C16H19N3O4S |
![Tubastatin-A](/CAS/20150408/GIF/1252003-15-8.gif) |
Tubastatin-A |
1252003-15-8 |
C20H21N3O2 |
![CAY10603](/CAS/20180808/GIF/1045792-66-2.gif) |
CAY10603 |
1045792-66-2 |
C22H30N4O6 |
![Nexturastat A](/CAS/20180713/GIF/1403783-31-2.gif) |
Nexturastat A |
1403783-31-2 |
C19H23N3O3 |
![SCRIPTAID](/CAS/GIF/287383-59-9.gif) |
SCRIPTAID |
287383-59-9 |
C18H18N2O4 |
![CAY10683 (SantacruzaMate A)](/CAS/20180713/GIF/1477949-42-0.gif) |
CAY10683 (SantacruzaMate A) |
1477949-42-0 |
C15H22N2O3 |
![AR-42](/CAS/GIF/935881-37-1.gif) |
AR-42 |
935881-37-1 |
C18H20N2O3 |
![TMP269](/CAS/20150408/GIF/1314890-29-3.gif) |
TMP269 |
1314890-29-3 |
C25H21F3N4O3S |
![HPOB](/CAS/20180713/GIF/1429651-50-2.gif) |
HPOB |
1429651-50-2 |
C17H18N2O4 |
![BRD73954](/CAS/20180713/GIF/1440209-96-0.gif) |
BRD73954 |
1440209-96-0 |
C16H16N2O3 |